TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03269916

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anti Mueller hormone
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: OTHER
Intervention: Anti Mueller hormone
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Estrogen
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: OTHER
Intervention: Estrogen
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follicle-Stimulating Hormone
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: OTHER
Intervention: Follicle-Stimulating Hormone
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antral alveolar cell count
Description: used to assess ovarian reserve parameters

Intervention type: OTHER
Group type: OTHER
Intervention: Antral alveolar cell count
Description: used to assess ovarian reserve parameters
Study: NCT04615234

Intervention type: DEVICE
Intervention: Pharmacogenomics test (PGx)
Description: The clinicians of the TGTG group patients receive the PGx test report within 48 hours and all the participants start the new treatment within 72 hours. According with both Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG) guidelines, the PGx report places the most ADs widespread in Italy, into three recommended categories: 1) use as directed (labelled as Green), 2) use with caution (labelled as Yellow), 3) use with extreme caution (labelled as Red)
Study: NCT02603237

Intervention type: OTHER
Group type: OTHER
Intervention: Glucose tolerance test
Description: Standardized oral glucose tolerance test (75 g oral glucose) and blood collection before and 2hrs after the glucose load

Intervention type: OTHER
Group type: OTHER
Intervention: Fat tolerance test
Description: Oral fat tolerance will be provided to fasting participants and blood samples will be collected before and 4 hrs after the fat load.
Study: NCT05360693

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: immediate implant placement without bone grafting
Description: After atraumatic extraction of the non-restorable tooth using periotome and luxators, osteotomy site preparation will be done \& patients will receive an immediate post-extraction implant without any grafting material in the socket between the residual labial bone and implant surface. After implant insertion, the labial bone dimensions of the buccal peri-implant defect will be measured using Automated Voxel Superimposition Method of CBCT scans. All the patients in this study had two scans; primary (preoperative) scan and secondary (Postoperative) scan, with standardization of the exposure parameters. All datafrom CBCT examinations were acquired in a DICOM format which were imported to OnDemand3D ®App software (Cybermed, Seoul, Korea). superimposition of DICOM sets of each patient using Fusion module of Ondemand 3D App software was done.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: immediate implant placement with socket bone grafting
Description: After atraumatic extraction of the non-restorable tooth using periotome and luxators, osteotomy site preparation will be done and patients will receive an immediate post-extraction implant with placing bovine bone graft (Bio-oss) in the socket between the residual labial bone and implant surface. After implant insertion, the labial bone dimensions of the buccal peri-implant defect will be measured using Automated Voxel Superimposition Method of CBCT scans. All the patients in this study had two scans; primary (preoperative) scan and secondary (Postoperative) scan, with standardization of the exposure parameters. All datafrom CBCT examinations were acquired in a DICOM format which were imported to OnDemand3D ®App software (Cybermed, Seoul, Korea). In order to ensure standardization and reproducibility of the CBCT cross sectional images used in this study, superimposition of DICOM sets of each patient using Fusion module of Ondemand 3D App software was done.
Study: NCT02867059

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (+)-SJ000557733
Description: (+)-SJ000557733 (SJ733), in short SJ733, will be the second PfATP4 inhibitor to enter clinical development after KAE609 (Novartis) which is currently in Phase 2 stage. KAE609 (cipargamin; previously known as NITD609) is a spirotetrahydro-β-carbolines (spiroindolone). KAE609 inhibits QP15C20_SJ733_Challenge Protocol_v2.0_26July2016 Page 28 of 110 PfATP4, which results in a disruption of parasite sodium homeostasis. Compared to KAE609, SJ733 has the potential to be a very fast acting, antimalarial drug for human therapeutic application and may have a different safety profile in human participants. Finally, SJ733 blocks parasite transmission in vivo at potencies close to those where it is efficacious in blood stages, indicating its potential for transmission blockade in humans.
Study: NCT05565066

Intervention type: DEVICE
Intervention: FNB group
Description: Fine-needle-biopsy (Echotip ProCore Needle)

Intervention type: DEVICE
Intervention: FNA group
Description: Fine-needle-aspiration (Echotip Needle)
Study: NCT02102685

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: VAC Therapy
Description: within the first three days the VAC therapy was placed , proceeding as follows : Wound cleaning was performed with irrigating solution and replacement of the sponges every 72 hours according to evolution, photographs were taken to assess the percentage of viable tissue and granulation. A Sample to culture was taken prior to placement of VAC therapy , during the use of it and at the time of removal of the system. When the wound presents clinical signs of improvement (elimination of purulent discharge and granulation tissue ) VAC therapy was withdrawn , and follow by delayed primary closure.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: TRADITIONAL THERAPY
Description: after surgical drainage, a culture was taken, photographs every three days (during hospital stay ) and secretion culture; daily cleaning stipulated by the service was perform. The control of the patients were made until wound closure (presence of epithelialization tissue) .
Study: NCT05464771

Intervention type: PROCEDURE
Intervention: Surgery for hip and knee replacement
Description: Elective inpatient surgery for hip and knee replacement
Study: NCT03067519

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fast track surgery
Description: early feeding and mobilization after surgery
Study: NCT03766581

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration
Study: NCT02241538

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pilates 1
Description: Combination of an educational booklet with exercises of the Pilates method. Patients will receive 6 sessions of treatment over a period of 6 weeks (1 session/week). The exercises of the Pilates method will be individualized to each patient´s needs (pragmatic treatment).
Study: NCT04144205

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Change of the fraction of inspired oxygen
Description: After the stabilization of cardiopulmonary bypass, in the first half of patients, fraction of inspired oxygen would be set at 0.5 and maintained for 5 minutes (T0), then it would be changed to 1.0 and maintained for 5 minutes (T1). Again, fraction of inspired oxygen would be resumed to be 0.5 and maintained for 5 minutes (T2).~In the other half of patients, the direction of change in fraction of inspired oxygen will be reversed as follows. It will be set at 1.0 and maintained for 5 minutes (T0), then changed to 0.5 and maintained for 5 minutes (T1), and finally to 1.0 and maintained for 5 minutes (T2).
Study: NCT02241538

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pilates 2
Description: Combination of an educational booklet with exercises of the Pilates method. Patients will receive 12 sessions of treatment over a period of 6 weeks (2 sessions/week). The exercises of the Pilates method will be individualized to each patient´s needs (pragmatic treatment).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pilates 3
Description: Combination of an educational booklet with exercises of the Pilates method. Patients will receive 18 sessions of treatment over a period of 6 weeks (3 sessions/week). The exercises of the Pilates method will be individualized to each patient´s needs (pragmatic treatment).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Patients will receive an educational booklet containing information about the anatomy of the spine and pelvis and the low back pain and recommendations regarding posture and movements involved in activities of daily living. The participants in this group did not receive additional exercise.
Study: NCT03244813

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized activity program
Description: Targeted physical activity
Study: NCT03067519

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional management
Description: Management per the primary surgeon
Study: NCT01838343

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Goal-directed ultrasound using a GE Vscan performed by a critical care fellow trained in ultrasonography.
Study: NCT03408041

Intervention type: OTHER
Intervention: Medical file data extraction
Description: Medical file data extraction
Study: NCT00580866

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JAS Brace
Description: For approximately 6 weeks after surgery, the brace will be utilized for a period of 30 minutes, 3 times per day. Participants will also receive physical therapy 3 times per week.
Study: NCT03278873

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: either AAV - CNGB3 or AAV - CNGA3
Description: Comparison of different dosages of either AAV - CNGB3 or AAV - CNGA3

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: either AAV - CNGB3 or AAV - CNGA3
Description: Comparison of different dosages of either AAV - CNGB3 or AAV - CNGA3

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: either AAV - CNGB3 or AAV - CNGA3
Description: Comparison of different dosages of either AAV - CNGB3 or AAV - CNGA3
Study: NCT03018561

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise and Cognitive testing
Description: Maximal cardiopulmonary test Rest cognitive testing

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and Cognitive testing
Description: Maximal cardiopulmonary test Rest cognitive testing
Study: NCT02822924

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Prostate artery embolization (PAE)
Description: Right femoral arterial puncture is performed under local anesthesia. The blood supply to the prostate is mapped by angiography of the iliac vessels and the prostate arteries. Microcatheters are used for super-selective catheterization of the right and left inferior vesicle arteries. Embolization is performed with a microcatheter to deliver microspheres of 300 micron diameter. The microsphere mixture is slowly injected under fluoroscopic guidance. The endpoint of embolization is flow stasis in the prostatic vessels with prostatic gland opacification, without reflux of the mixture to undesired arteries.
Study: NCT00680966

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression/Functional Family Therapy
Description: ACWD- Cognitive behavioral group therapy for depressed adolescents FFT - Family therapy to address substance use disorders in adolescents

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression/Functional Family Therapy
Description: ACWD- Cognitive behavioral group therapy for depressed adolescents FFT - Family therapy to address substance use disorders in adolescents

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression/Functional Family Therapy
Description: ACWD- Cognitive behavioral group therapy for depressed adolescents FFT - Family therapy to address substance use disorders in adolescents
Study: NCT01076270

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: plerixafor
Description: Given SC

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: filgrastim
Description: Given SC

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peripheral blood stem cell transplantation
Description: Infusion of peripheral blood stem cells

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic hematopoietic stem cell transplantation
Description: Infusion of hematopoietic stem cells
Study: NCT01172054

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAX128
Description: one IM injection

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One IM injection
Study: NCT05202899

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sugammadex
Description: The use of sugammadex
Study: NCT00751270

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AdV-tk
Description: Three different dosing levels of AdV-tk (3x10e10, 1x10e11, 3X10e11) were evaluated. A single injection of AdV-tk at the assigned dose level was administered, followed by 14 days of the oral prodrug valacyclovir. Patients then received standard of care radiation therapy and chemotherapy.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AdV-tk
Description: Three different dosing levels of AdV-tk (3x10e10, 1x10e11, 3X10e11) were evaluated. A single injection of AdV-tk at the assigned dose level was administered, followed by 14 days of the oral prodrug valacyclovir. Patients then received standard of care radiation therapy and chemotherapy.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Description: The oral prodrug valacyclovir was given beginning 1-3 days following the AdV-tk. Valacyclovir tablets were taken three times a day for a total of 14 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Description: The oral prodrug valacyclovir was given beginning 1-3 days following the AdV-tk. Valacyclovir tablets were taken three times a day for a total of 14 days.
Study: NCT04745429

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: breathing exercises, cold exposure and meditation
Description: It is a combination of exercises that include breathing exercises, cold exposure and meditation
Study: NCT04469036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Pediatric Trauma Center
Description: Telehealth
Study: NCT00812864

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Pharmacokinetic of its metabolites.~Capecitabine, 1250 mg/m2 twice a day
Study: NCT01487551

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paquinimod
Description: Hard gelatine capsules 3.0 mg/day for 8 weeks
Study: NCT01880398

Intervention type: OTHER
Intervention: Kshar Sutra
Description: The Kshar Sutra was a standard medicated thread smeared with Kshar of Apamarga (Achyranthus aspera), Shnuhi (Eforbia Nerrifolia) which has quality of cutting and Haridra(Curcuma Longa) which is used as a antiseptic. The ph value of the thread thus prepared was determined and its sterilization effected by ultraviolet radiation. The alkalinity of Kshar Sutra was 9.2ph.
Study: NCT01325636

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cell therapy
Description: Injection of specific T cell by intravenous way with a posology of 1000 to 5000 CD3 IFN γ+ / kg.~A second injection could be made at day 21
Study: NCT01628484

Intervention type: OTHER
Group type: OTHER
Intervention: prick lancet
Description: For the pricking skin preparation, sterile prick lancets for 1mm point skin testing will be used. They are used for allergy diagnostics in daily routine.

Intervention type: OTHER
Group type: OTHER
Intervention: Tape stripping
Description: For the tape stripping in the skin preparation test conventional self adhesive tape by Tesafilm® is used.
Study: NCT03466697

Intervention type: OTHER
Group type: OTHER
Intervention: Glucose injection/Normal saline injection
Description: Before each PET scan, subject will be injected either glucose or normal saline.
Study: NCT01705639

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: All subjects receive the same dose of melatonin
Study: NCT01803373

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (reference)
Description: One tablet equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.
Study: NCT01628484

Intervention type: OTHER
Group type: OTHER
Intervention: Microneedle
Description: To induce a large number of microchannels with a maximal depth of 150µm into the cornea layer a small patch of 351 tiny needles is used, which is on the market in the US and is intended for preparing the skin for transdermal application of topical dermatology products.
Study: NCT02840188

Intervention type: OTHER
Intervention: Radius tilt angle
Description: Fracture classification in children. Tilt angle measurement of the distal radius growth plate.

Intervention type: OTHER
Intervention: Radius tilt angle
Description: Fracture classification in children. Tilt angle measurement of the distal radius growth plate.
Study: NCT00596674

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counts
Description: 8 weeks of classes focused on health behavior change, individualized goal setting and 3 months of follow-up phone support

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Attention Control
Description: 8 weeks of classes on general health information topics followed by 3 months of phone calls to solicit questions
Study: NCT03073083

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hamstring tendon autograft
Description: ACL reconstruction surgery with hamstring tendon
Study: NCT01803373

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (reference)
Description: One tablet equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (reference)
Description: One tablet equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.
Study: NCT03073083

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pattella tendon autograft
Description: ACL reconstruction surgery with patella tendon

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadriceps tendon autograft
Description: ACL reconstruction surgery with quadriceps tendon
Study: NCT04497363

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brainsonix Pulsar 1002
Description: Each participant will undergo 8 consecutive weekly sessions (each session is 10 minutes long) of focused ultrasound with the Brainsonix Pulsar 1002 device.
Study: NCT01449396

Intervention type: OTHER
Group type: OTHER
Intervention: Bed Rest
Description: Bed rest during 25 minutes on day 1, 4 and 6 of ovarian stimulation, before and after embryo transfer

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Acupuncture
Description: Sham acupuncture during 25 minutes on day 1, 4 and 6 of ovarian stimulation, before and after embryo transfer

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture during 25 minutes on day 1, 4 and 6 of ovarian stimulation, before and after embryo transfer
Study: NCT01803373

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (reference)
Description: One tablet equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (reference)
Description: One tablet equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A (reference)
Description: One tablet equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: Five 20-mg water dispersable tablets equivalent to a single 100-mg dose of TMC207 taken orally (by mouth) once.
Study: NCT02640924

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton radiotherapy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency Ablation
Study: NCT03239769

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thyroidectomy
Description: Thyroidectomies have different approaches. The aim of this study was to evaluate and compare the aesthetic effects of different access procedures in patients with differentiated thyroid carcinoma (DTC).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thyroidectomy
Description: Thyroidectomies have different approaches. The aim of this study was to evaluate and compare the aesthetic effects of different access procedures in patients with differentiated thyroid carcinoma (DTC).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thyroidectomy
Description: Thyroidectomies have different approaches. The aim of this study was to evaluate and compare the aesthetic effects of different access procedures in patients with differentiated thyroid carcinoma (DTC).